|
RBM26 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.564000E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.069800E-01 |
| Normal-vs-Stage2 |
8.691600E-01 |
| Normal-vs-Stage3 |
2.673700E-02 |
| Normal-vs-Stage4 |
3.281600E-03 |
| Stage1-vs-Stage2 |
3.389000E-01 |
| Stage1-vs-Stage3 |
1.839240E-01 |
| Stage1-vs-Stage4 |
2.414300E-02 |
| Stage2-vs-Stage3 |
1.006440E-01 |
| Stage2-vs-Stage4 |
3.400300E-02 |
| Stage3-vs-Stage4 |
3.986400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.073700E-02 |
| Normal-vs-AfricanAmerican |
1.404050E-02 |
| Normal-vs-Asian |
1.678410E-01 |
| Caucasian-vs-AfricanAmerican |
1.370760E-01 |
| Caucasian-vs-Asian |
8.498200E-02 |
| AfricanAmerican-vs-Asian |
2.716500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.819700E-03 |
| Normal-vs-Female |
8.419800E-01 |
| Male-vs-Female |
3.158400E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.671900E-02 |
| Normal-vs-Age(41-60Yrs) |
3.739200E-01 |
| Normal-vs-Age(61-80Yrs) |
4.339700E-02 |
| Normal-vs-Age(81-100Yrs) |
6.861900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.680570E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.140200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.192200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.169800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.361600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.247600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.804630E-01 |
| Normal-vs-Grade 2 |
7.531600E-01 |
| Normal-vs-Grade 3 |
9.758500E-03 |
| Normal-vs-Grade 4 |
1.102240E-03 |
| Grade 1-vs-Grade 2 |
2.264400E-01 |
| Grade 1-vs-Grade 3 |
8.395500E-03 |
| Grade 1-vs-Grade 4 |
2.117200E-03 |
| Grade 2-vs-Grade 3 |
5.239900E-03 |
| Grade 2-vs-Grade 4 |
7.169800E-04 |
| Grade 3-vs-Grade 4 |
1.818400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.130200E-01 |
| Normal-vs-ccB subtype |
4.466000E-02 |
| ccA subtype-vs-ccB subtype |
1.622310E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.396800E-01 |
| Normal-vs-N1 |
6.538500E-02 |
| N0-vs-N1 |
2.789200E-01 |
|
|
